Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Equity Ratio (2020 - 2025)

Biofrontera has reported Equity Ratio over the past 6 years, most recently at 0.37 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.37 for Q4 2025, up 82.92% from a year ago — trailing twelve months through Dec 2025 was 0.37 (up 82.92% YoY), and the annual figure for FY2025 was 0.37, up 82.92%.
  • Equity Ratio for Q4 2025 was 0.37 at Biofrontera, up from 0.17 in the prior quarter.
  • Over the last five years, Equity Ratio for BFRIW hit a ceiling of 0.51 in Q2 2024 and a floor of 1.13 in Q3 2021.
  • Median Equity Ratio over the past 5 years was 0.21 (2021), compared with a mean of 0.12.
  • Biggest five-year swings in Equity Ratio: surged 881.26% in 2024 and later plummeted 156.06% in 2025.
  • Biofrontera's Equity Ratio stood at 0.21 in 2021, then skyrocketed by 120.27% to 0.47 in 2022, then tumbled by 63.43% to 0.17 in 2023, then grew by 16.89% to 0.2 in 2024, then surged by 82.92% to 0.37 in 2025.
  • The last three reported values for Equity Ratio were 0.37 (Q4 2025), 0.17 (Q3 2025), and 0.23 (Q2 2025) per Business Quant data.